The problem right now is that there might be the old stigma of shorts from the old AXON ticker. I say give it time for AXGT to take off. There are still multiple catalysts in 2019. You have 2 more interim readouts for GM2 in 2019 2 more interim readouts for PD in 2019 Trial initiation for GM1 study expected in coming weeks/months possibly 1 t 2 interim updates in 2019 for GM1 study. Initiation of the OPMD silence and replace program from Benitec biopharma expected 2nd half of 2019 Then any other potential cash infusion news as well. It will take some time but I think it can get there.